Literature DB >> 28652484

Identifying those infected with hepatitis C virus.

Eric M Yoshida1, Eberhard Renner2, Philip Wong3, Mel Krajden4.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28652484      PMCID： PMC5489395          DOI： 10.1503/cmaj.733099

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  6 in total

1.  A Canadian screening program for hepatitis C: is now the time?

Authors:  Hemant A Shah; Jenny Heathcote; Jordan J Feld
Journal:  CMAJ       Date:  2013-09-30       Impact factor: 8.262

Review 2.  Update on Current Evidence for Hepatitis C Therapeutic Options in HCV Mono-infected Patients.

Authors:  Mark W Hull; Eric M Yoshida; Julio S G Montaner
Journal:  Curr Infect Dis Rep       Date:  2016-07       Impact factor: 3.725

3.  Sustained responders have better quality of life and productivity compared with treatment failures long after antiviral therapy for hepatitis C.

Authors:  Ava A John-Baptiste; George Tomlinson; Priscilla C Hsu; Mel Krajden; E Jenny Heathcote; Audrey Laporte; Eric M Yoshida; Frank H Anderson; Murray D Krahn
Journal:  Am J Gastroenterol       Date:  2009-06-30       Impact factor: 10.864

4.  Recommendations on hepatitis C screening for adults.

Authors:  Roland Grad; Brett Thombs; Marcello Tonelli; Maria Bacchus; Richard Birtwhistle; Scott Klarenbach; Harminder Singh; Veronique Dorais; Nathalie Holmes; Wendy Martin; Rachel Rodin; Alejandra Jaramillo Garcia
Journal:  CMAJ       Date:  2017-04-24       Impact factor: 8.262

5.  Health utilities and psychometric quality of life in patients with early- and late-stage hepatitis C virus infection.

Authors:  Priscilla C Hsu; Carole A Federico; Mel Krajden; Eric M Yoshida; Karen E Bremner; Frank H Anderson; Alan A Weiss; Murray D Krahn
Journal:  J Gastroenterol Hepatol       Date:  2012-01       Impact factor: 4.029

6.  Cost-effectiveness of screening for hepatitis C in Canada.

Authors:  William W L Wong; Hong-Anh Tu; Jordan J Feld; Tom Wong; Murray Krahn
Journal:  CMAJ       Date:  2015-01-12       Impact factor: 8.262
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.